186 related articles for article (PubMed ID: 23774212)
1. mTOR signaling feedback modulates mammary epithelial differentiation and restrains invasion downstream of PTEN loss.
Ghosh S; Varela L; Sood A; Park BH; Lotan TL
Cancer Res; 2013 Aug; 73(16):5218-31. PubMed ID: 23774212
[TBL] [Abstract][Full Text] [Related]
2. PI3K/mTOR signaling regulates prostatic branching morphogenesis.
Ghosh S; Lau H; Simons BW; Powell JD; Meyers DJ; De Marzo AM; Berman DM; Lotan TL
Dev Biol; 2011 Dec; 360(2):329-42. PubMed ID: 22015718
[TBL] [Abstract][Full Text] [Related]
3. Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.
Hagenbeek TJ; Wu X; Choy L; Sanchez-Irizarry C; Seshagiri S; Stinson J; Siebel CW; Spits H
Cancer Lett; 2014 May; 346(2):237-48. PubMed ID: 24384093
[TBL] [Abstract][Full Text] [Related]
4. PTEN is required to maintain luminal epithelial homeostasis and integrity in the adult mammary gland.
Shore AN; Chang CH; Kwon OJ; Weston MC; Zhang M; Xin L; Rosen JM
Dev Biol; 2016 Jan; 409(1):202-217. PubMed ID: 26526198
[TBL] [Abstract][Full Text] [Related]
5. A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition.
Cheng H; Liu P; Zhang F; Xu E; Symonds L; Ohlson CE; Bronson RT; Maira SM; Di Tomaso E; Li J; Myers AP; Cantley LC; Mills GB; Zhao JJ
Cancer Res; 2014 Jan; 74(1):15-23. PubMed ID: 24322983
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation.
Furgeson SB; Simpson PA; Park I; Vanputten V; Horita H; Kontos CD; Nemenoff RA; Weiser-Evans MC
Cardiovasc Res; 2010 May; 86(2):274-82. PubMed ID: 20051384
[TBL] [Abstract][Full Text] [Related]
7. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
[TBL] [Abstract][Full Text] [Related]
8. MiR-486 regulates lactation and targets the PTEN gene in cow mammary glands.
Li D; Xie X; Wang J; Bian Y; Li Q; Gao X; Wang C
PLoS One; 2015; 10(3):e0118284. PubMed ID: 25738494
[TBL] [Abstract][Full Text] [Related]
9. PI3K-PTEN dysregulation leads to mTOR-driven upregulation of the core clock gene BMAL1 in normal and malignant epithelial cells.
Matsumoto CS; Almeida LO; Guimarães DM; Martins MD; Papagerakis P; Papagerakis S; Leopoldino AM; Castilho RM; Squarize CH
Oncotarget; 2016 Jul; 7(27):42393-42407. PubMed ID: 27285754
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
Tanaka K; Babic I; Nathanson D; Akhavan D; Guo D; Gini B; Dang J; Zhu S; Yang H; De Jesus J; Amzajerdi AN; Zhang Y; Dibble CC; Dan H; Rinkenbaugh A; Yong WH; Vinters HV; Gera JF; Cavenee WK; Cloughesy TF; Manning BD; Baldwin AS; Mischel PS
Cancer Discov; 2011 Nov; 1(6):524-38. PubMed ID: 22145100
[TBL] [Abstract][Full Text] [Related]
12. Lab review: Molecular dissection of the signal transduction pathways associated with PTEN deletion-induced optic nerve regeneration.
Huang H; Kaur S; Hu Y
Restor Neurol Neurosci; 2019; 37(6):545-552. PubMed ID: 31839616
[TBL] [Abstract][Full Text] [Related]
13. EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells.
Li T; Yang Y; Li X; Xu C; Meng L
Mol Cell Biochem; 2012 Feb; 361(1-2):19-29. PubMed ID: 21952748
[TBL] [Abstract][Full Text] [Related]
14. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
[TBL] [Abstract][Full Text] [Related]
15. mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.
Boudra R; Lagrafeuille R; Lours-Calet C; de Joussineau C; Loubeau-Legros G; Chaveroux C; Saru JP; Baron S; Morel L; Beaudoin C
Cell Cycle; 2016 May; 15(10):1352-62. PubMed ID: 27050906
[TBL] [Abstract][Full Text] [Related]
16. Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer.
Chun SH; Jung CK; Won HS; Kang JH; Kim YS; Kim MS
Head Neck; 2015 May; 37(5):636-43. PubMed ID: 24616007
[TBL] [Abstract][Full Text] [Related]
17. PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis.
Schade B; Rao T; Dourdin N; Lesurf R; Hallett M; Cardiff RD; Muller WJ
J Biol Chem; 2009 Jul; 284(28):19018-26. PubMed ID: 19435886
[TBL] [Abstract][Full Text] [Related]
18. Basal but not luminal mammary epithelial cells require PI3K/mTOR signaling for Ras-driven overgrowth.
Plichta KA; Mathers JL; Gestl SA; Glick AB; Gunther EJ
Cancer Res; 2012 Nov; 72(22):5856-66. PubMed ID: 23010075
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.
McCubrey JA; Steelman LS; Kempf CR; Chappell WH; Abrams SL; Stivala F; Malaponte G; Nicoletti F; Libra M; Bäsecke J; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Cocco L; Martelli AM
J Cell Physiol; 2011 Nov; 226(11):2762-81. PubMed ID: 21302297
[TBL] [Abstract][Full Text] [Related]
20. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Hu X; Pandolfi PP; Li Y; Koutcher JA; Rosenblum M; Holland EC
Neoplasia; 2005 Apr; 7(4):356-68. PubMed ID: 15967113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
